A comparative study between radioreceptor assay and radioimmunoassay for hCG in patients with trophoblastic disease
- PMID: 703989
A comparative study between radioreceptor assay and radioimmunoassay for hCG in patients with trophoblastic disease
Abstract
The results of a urinary quantitative radioreceptor assay (RRA) were compared with those obtained with an established specific radioimmunoassay (RIA) for hCG in a group of patients with trophoblastic disease. A good correlation (r = 0.95) was found between the two methods for values greater than 10 mIU/ml of hCG. A specific RIA for hCG should be used when the hCG levels fall below 10 mIU/ml. With the use of this urinary RRA, the clinician can follow patients with hydatidiform more for up to 10 weeks after evacuation and have the hCG titer available on the same day the specimen is obtained.
Similar articles
-
Application of the radioreceptor assay for human chorionic gonadotropin in pregnancy testing and management of trophoblastic disease.Obstet Gynecol. 1977 Sep;50(3):324-32. Obstet Gynecol. 1977. PMID: 197458
-
Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.Obstet Gynecol. 1977 Aug;50(2):172-81. Obstet Gynecol. 1977. PMID: 195242
-
Evaluation and clinical application of the quantitative radioreceptor assay for serum hCG.Obstet Gynecol. 1979 Dec;54(6):737-45. Obstet Gynecol. 1979. PMID: 514561
-
The need for an hCG assay that appropriately detects trophoblastic disease and other hCG-producing cancers.J Reprod Med. 2006 Oct;51(10):793-811. J Reprod Med. 2006. PMID: 17086808 Review.
-
Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels.J Reprod Med. 1994 Mar;39(3):193-200. J Reprod Med. 1994. PMID: 8035374 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources